The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Mylan; SERVIER
A randomized, non-comparative, phase II study of maintenance OSE2101 vaccine alone or in combination with nivolumab (nivo) or FOLFIRI after induction with FOLFIRINOX in patients (Pts) with advanced pancreatic ductal adenocarcinoma (aPDAC): First interim results of the TEDOPAM GERCOR D17-01 PRODIGE 63 STUDY.
 
Marc Hilmi
No Relationships to Disclose
 
Emmanuel Mitry
No Relationships to Disclose
 
Anthony Turpin
No Relationships to Disclose
 
Olivier Bouché
Consulting or Advisory Role - Amgen; AstraZeneca; MSD Oncology; Pierre Fabre; Roche; SERVIER
Speakers' Bureau - Amgen; Bayer; Merck Serono; Pierre Fabre; Sanofi; Servier
 
Jean-Philippe Metges
Honoraria - BMS; Lilly; Novartis; Sanofi; SynCoreBio
Travel, Accommodations, Expenses - Amgen; Amgen; LEO Pharma; MSD Oncology; MSD Oncology; MSD Oncology
 
François Ghiringhelli
Honoraria - roche
Research Funding - AstraZeneca/MedImmune (Inst)
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Roche/Genentech; Roche/Genentech
 
Isabelle Trouilloud
Honoraria - SERVIER
 
Gaël Roth
Honoraria - Ipsen; MSD; SERVIER
Consulting or Advisory Role - Accord Healthcare; SERVIER
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Ipsen
 
Isabelle Baumgaertner
No Relationships to Disclose
 
Christophe Borg
Consulting or Advisory Role - Bayer; MSD Oncology; Pierre Fabre; Roche/Genentech
Research Funding - Roche/Genentech (Inst)
 
Hanifa Ammarguellat
No Relationships to Disclose
 
Marielle Guillet
Honoraria - Bayer Health; SERVIER
Travel, Accommodations, Expenses - Janssen; Mayoly-Spindler
 
Yves Rinaldi
No Relationships to Disclose
 
Thierry Lecomte
Consulting or Advisory Role - Amgen; AstraZeneca; Ipsen; Merck Serono; Pierre Fabre; Sanofi; SERVIER
Travel, Accommodations, Expenses - Ipsen; Servier/Pfizer
 
Christophe Louvet
Consulting or Advisory Role - Amgen; Merck; MSD Oncology; Roche
Travel, Accommodations, Expenses - Merck; Roche
 
Aurélien Lambert
Consulting or Advisory Role - Advanced Accelerator Applications; AstraZeneca/MedImmune; Bayer; GlaxoSmithKline; Ipsen; Janssen; Merck KGaA; Merck Serono; Pierre Fabre; Servier/Pfizer
Travel, Accommodations, Expenses - Merck KGaA; Pfizer
 
Vincent Hautefeuille
Honoraria - Advanced Accelerator Applications; Amgen; Ipsen; Merck KGaA; Novartis; Sanofi; SERVIER
Research Funding - Ipsen
Travel, Accommodations, Expenses - Amgen; Ipsen; Novartis; Pfizer; Sanofi
 
Marie-Line Garcia-Larnicol
No Relationships to Disclose
 
Julie Henriques
No Relationships to Disclose
 
Cindy Neuzillet
Honoraria - Amgen; AstraZeneca; Baxter; Bristol-Myers Squibb; Fresenius Kabi; Incyte; Merck; MSD Oncology; Mylan; Novartis; Nutricia; Pierre Fabre; Roche; Sanofi; SERVIER
Consulting or Advisory Role - Incyte
Research Funding - AstraZeneca (Inst); Fresenius Kabi (Inst); Nutricia (Inst); OSE Immunotherapeutics (Inst); Roche (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Amgen; Merck; MSD Oncology; Mylan; OSE Immunotherapeutics